Search results
Results from the WOW.Com Content Network
The fundamental goal of treatment should be the prevention of the important endpoints of hypertension, such as heart attack, stroke and heart failure. Patient age, associated clinical conditions and end-organ damage also play a part in determining dosage and type of medication administered. [ 3 ]
Guidelines for treating resistant hypertension have been published in the UK [45] and US. [46] It has been proposed that a proportion of resistant hypertension may be the result of chronic high activity of the autonomic nervous system, known as "neurogenic hypertension". [47] Low adherence to treatment is an important cause of resistant ...
Hypertension occurs in around 0.2 to 3% of newborns; however, blood pressure is not measured routinely in healthy newborns. [42] Hypertension is more common in high risk newborns. A variety of factors, such as gestational age, postconceptional age, and birth weight need to be taken into account when deciding if blood pressure is normal in a ...
The treatment for hypertension will depend on how high your blood pressure is and what’s causing it. For example, elevated blood pressure and hypertension stage 1 may require some lifestyle changes.
The new triple combination medication for treating hypertension is called GMRx2. Researchers estimate that about 1.28 billion adults around the world have hypertension , also known as high blood ...
Reserpine is a drug that is used for the treatment of high blood pressure, usually in combination with a thiazide diuretic or vasodilator. [1] Large clinical trials have shown that combined treatment with reserpine plus a thiazide diuretic reduces mortality of people with hypertension.
The dangerous effects of high blood pressure are highlighted in a new report by the World Health Organization that identifies the condition as one of the world’s leading risk factors for death ...
Angiotensin II receptor blockers are used primarily for the treatment of hypertension where the patient is intolerant of ACE inhibitor therapy primarily because of persistent and/or dry cough. [ 6 ] [ 7 ] They do not inhibit the breakdown of bradykinin or other kinins , and are thus only rarely associated with the persistent dry cough and/or ...